Compare BBW & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBW | CMPS |
|---|---|---|
| Founded | 1997 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 696.0M | 662.5M |
| IPO Year | 2004 | 2020 |
| Metric | BBW | CMPS |
|---|---|---|
| Price | $63.49 | $7.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $67.71 | $16.43 |
| AVG Volume (30 Days) | 443.1K | ★ 1.2M |
| Earning Date | 12-04-2025 | 02-26-2026 |
| Dividend Yield | ★ 1.40% | N/A |
| EPS Growth | ★ 15.02 | N/A |
| EPS | ★ 4.36 | N/A |
| Revenue | ★ $525,767,000.00 | N/A |
| Revenue This Year | $8.05 | N/A |
| Revenue Next Year | $4.31 | N/A |
| P/E Ratio | $14.46 | ★ N/A |
| Revenue Growth | ★ 6.17 | N/A |
| 52 Week Low | $32.55 | $2.25 |
| 52 Week High | $75.85 | $7.15 |
| Indicator | BBW | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 68.46 | 60.85 |
| Support Level | $58.69 | $6.27 |
| Resistance Level | $66.17 | $7.14 |
| Average True Range (ATR) | 2.61 | 0.39 |
| MACD | 0.75 | -0.00 |
| Stochastic Oscillator | 80.66 | 80.84 |
Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.